Author: Myesha Broadie

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.

The Health Ministry says its import permit department, is monitoring all donations and personal imports, following reports that over four medicines may have resulted in the deaths of 66 children in The Gambia.

On Wednesday, the World Health Organisation, WHO said a product alert was issued for over four cough and cold syrups, made by maiden pharmaceuticals in India, following the suspected deaths.

The products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

According to Health Minister Dr. Christopher Tufton, records indicate that neither the manufacturer nor the product is registered with the ministry, and therefore the possibility of the product entering Jamaica is remote.

He noted however, that the ministry has put in place measures to further reduce the risk of the product entering the country.

Dr. Tufton said to date, the manufacturer has not provided guarantees to the WHO on the safety and quality of these products, adding that lab analysis of samples confirm that they contain unacceptable amounts of contaminants.